Promotie onderzoek

KNMP stelt wetenschappelijk onderzoek voorop. Hier kunt u de meest recente onderzoeken vinden.
Er zijn16resultaten gevonden
Klinische farmacologie

Deprescribing of antihypertensives in the elderly

  • Universiteit Erasmus Medisch Centrum Rotterdam
  • Promovendus Dimokrat Hassan
  • Promoters Patricia van den Bemt Liset van Dijk
  • Co-Promoters Jorie Versmissen Karin Hek
  • Jaar 2019 - 2023

The (positive) effects of antihypertensive drugs in the cardiovascular risk management are undoubted. However, like all drugs, antihypertensive drugs also have negative side-effects. Especially the elderly, are more susceptible for these adverse effects. It's not clear whether the benefits outweight the risks. So is it possible to deprescribe antihypertensive drugs and minimise risks for adverse events, while maintining blood-pressure levels in accordance with guidelines?  

Farmacokinetiek en -dynamiek

Dose individualization of Beta-lactam and Ciprofloxacin in ICU patients: To TDM or not to TDM

  • Universiteit Erasmus Medisch Centrum Rotterdam
  • Promovendus Alan Abdulla
  • Promoters Birgit Koch
  • Co-Promoters Rik Endeman Anouk Muller
  • Jaar 2018 - 2022
  • A prospective observational PK/PD to study the target attainment for β-lactam antibiotics in critical ill patients and its associated risk factors.
  • A multi-centre, randomised controlled trial to assess the efficacy and cost-effectiveness of model-based TDM of beta-lactam and fluoroquinolone antibiotics.
Farmacokinetiek en -dynamiek

PK/PD of betalactamantibiotics

  • Universiteit Erasmus Medisch Centrum Rotterdam
  • Promovendus Eveline Roelofsen
  • Promoters Birgit Koch
  • Co-Promoters Brenda de Winter Anouk Muller
  • Jaar 2019 - 2023
  1. Optimasation of the flucloxacillin absorptiontest.
  2. PK modeeling of cefotaxim in critically ill patients.
  3. PK modeling of flucloxacillin in mice.
Medicatieveiligheid

Clinical rules in de huiartsenpraktijk

  • Universiteit Erasmus Medisch Centrum Rotterdam
  • Promovendus Fauzia Chitanie
  • Promoters Hugo van der Kuy
  • Co-Promoters Floor van Rosse Kees van Boven
  • Jaar 2019 - 2024

Meerwaarde van clinical rules in de eerste lijn.

Medicatieveiligheid

Alert Fatigue

  • Universiteit Erasmus Medisch Centrum Rotterdam
  • Promovendus Bob van der Loo
  • Promoters Hugo van der Kuy
  • Co-Promoters Heleen van der Sijs
  • Jaar 2020 - 2024

Optimalisatie van het clinical decision support system.

Farmacokinetiek en -dynamiek

Improving the pharmaceutical care for (liver) transplant recipients

  • Universiteit Erasmus Medisch Centrum Rotterdam
  • Promovendus Midas B. Mulder
  • Promoters Prof. Dr. Herold Metselaar
  • Co-Promoters Dr. B.C.M. de Winter Dr. S. Darwish Murad
  • Jaar 2019 - 2023

Part 1: Optimizing ribavirin therapy in transplant recipients with a chronic hepatitis E virus infection by devoloping a NONMEM model for ribavirin. Part 2: Improving immunosuppressive therapy in liver transplant recipients by performing 2 RCT's in which different immunosuppresive strategies will be compared to modify the tacrolimus related toxicity in this population. Part 3: Evaluate the contribution of an outpatient medication service for liver transplant recipients.

Therapietrouw

Resistant HYpertension: MEasure To ReaCh Targets (RHYME-RCT)

  • Universiteit Erasmus Medisch Centrum Rotterdam
  • Promovendus Laura Peeters
  • Promoters Prof. dr. Teun van Gelder
  • Co-Promoters Dr. B.C.P. Koch Dr. J. Versmissen
  • Jaar 2018 - 2022

RHYME-RCT is a multi-center randomized controlled trial to identify and improve non-adherence in patients with resistant hypertension and are included from 10 peripheral and 2 academic hospitals. Non-adherence is measured by means of a validated dried blood spot method. This method includes 17 antihypertensive drugs from different drug classes.

Pagina 1 van 3